MELANOMA OF UNKNOWN PRIMARY
Clinical trials for MELANOMA OF UNKNOWN PRIMARY explained in plain language.
Never miss a new study
Get alerted when new MELANOMA OF UNKNOWN PRIMARY trials appear
Sign up with your email to follow new studies for MELANOMA OF UNKNOWN PRIMARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
PET scans may let melanoma patients stop therapy early
Disease control OngoingThis study tests whether doctors can safely stop standard anti-PD-1 immunotherapy earlier than usual for people with advanced melanoma that cannot be removed surgically. Using PET/CT scans and tumor biopsies as guides, researchers aim to see if shorter treatment still keeps the c…
Matched conditions: MELANOMA OF UNKNOWN PRIMARY
Phase: PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated May 26, 2026 08:48 UTC
-
New combo aims to shrink melanoma before surgery
Disease control OngoingThis study tests whether adding an experimental drug (CMP-001) to the immunotherapy pembrolizumab works better than pembrolizumab alone for people with melanoma that can be surgically removed. About 60 adults with stage III melanoma will receive treatment before surgery to see if…
Matched conditions: MELANOMA OF UNKNOWN PRIMARY
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
Major trial tests which immune drug best stops melanoma comeback
Disease control OngoingThis study tested whether the immunotherapy drug ipilimumab works better than high-dose interferon alfa-2b at preventing melanoma from coming back after surgery. About 1,673 patients with high-risk stage III–IV melanoma that was fully removed took part. The main goal was to see w…
Matched conditions: MELANOMA OF UNKNOWN PRIMARY
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:53 UTC